NewsRx

Search our medical news database

AspenBio Pharma, Inc.

Appendicitis test-related patent published

Published in Medical Verdicts and Law Weekly, March 9th, 2006

AspenBio Pharma, Inc., (APNB) announced that its U.S. and international patent applications entitled "Methods and devices for diagnosis of appendicitis" have recently been published by the United States Patent Office and the International Bureau of the World Intellectual Property Organization.

AspenBio has also recently filed a further separate patent application seeking to expand its worldwide position of intellectual property protection associated with this technology. In connection with the advancement of the test, the company has also signed a licensing agreement, securing access to a critical technology element which ensures a continuing supply of an important test...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook